Your health is covered at every stage
Cardiometabolic Risk Unit
This specialised unit, under the Department of Internal Medicine at Hospitales San Roque, aims to treat people at risk of developing circulatory system diseases
Diseases of the circulatory system are the most common cause of death in Spain. According to the latest data published by the National Statistical Institute, in the year 2014 the mortality rate for cardiovascular disease was 252.7 deaths per 100,000 inhabitants. Within this group of diseases, ischemic heart disease (acute myocardial infarction, angina) is the leading cause of death in men, and stroke is the leading cause of death in women. Moreover, it is particularly relevant that in up to a third of cardiac mortality cases, sudden death may be the first sign in an apparently healthy subject. Diabetes, hypertension, dyslipidaemia, obesity, smoking habits, a sedentary lifestyle and stress, as well as ageing itself, are directly related to the onset of cardiovascular diseases.
The presence of these risk factors or unhealthy lifestyle habits are prominent in our days. The study firstname.lastname@example.org [carried out by CIBERDEM, the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, and the Carlos III Health Institute (Ministry of Science and Innovation), with the collaboration of the Spanish Diabetes Society (SED) and the Spanish Diabetes Federation (FED)], states that 13.8% of the population have diabetes in our country (and up to 6% of them have not been diagnosed), 28.2% are obese, 41.2% have high blood pressure, 27.81% smoke and 50.3% lead a sedentary lifestyle.
In the Canary Islands, the second autonomous community where the mortality rate increased the most during 2014, diabetes and obesity have reached even higher rates. Diabetes is the second leading cause of death in women and the third in men in our region, which make up 5% of all deaths (2% higher than the rest of Spain). With regard to overweight/obesity, it is also important to highlight a particularly relevant fact: its rate has increased at younger ages and it has almost reached 50% in school-age children.
It is therefore essential to establish strategies to correctly identify cardiovascular risk and to take early preventive measures in order to reduce cardiovascular disease occurrence and its associated mortality.
That is why Hospitales San Roques created a new unit specialised in Cardiometabolic Risk within the Department of Internal Medicine of Hospitales San Roque in Las Palmas de Gran Canaria, which is led by Dr. Raju Daryanani. This new unit has also recruited Dr Susana Tello Blasco, who holds a Master’s Degree in Cardiovascular Disease and a Master’s Degree in Clinical Research Methodology from the University of Barcelona and has vast experience in this field thanks to the work she carried out with Dr José Sabán, responsible for the Endothelium and Cardiometabolic Medicine Unit at the Ramón y Cajal University Hospital in Madrid (a renowned unit at national level), where these successful techniques are regularly applied.
Thus, we place our specialised unit at the disposal of our patients, offering state-of-the-art technologies, a comprehensive and early care aimed particularly at patients with high blood pressure, diabetes, dyslipidaemia or obesity as well those who smoke, have a sedentary lifestyle, have been diagnosed with autoimmune diseases associated to a greater baseline risk such as rheumatoid arthritis or systemic lupus erythematosus, premenopausal/menopausal women or women with a history of preeclampsia or gestational diabetes, and any other person interested in knowing their cardiovascular condition. A risk assessment is carried out to determine the likelihood of suffering a cardiovascular event in the next 10 years and an innovative medical evaluation of the patient’s current arterial stiffness (premature age-related arterial hardening is associated to several cardiovascular risk factors) which allows us to develop personalised prevention strategies as well as to follow up the patient’s response to therapeutic changes.